Exchange: OTC·Updated 03:32 PM EDT

ISLMF InSilico Medicine Cayman TopCo

$6.10
$0.34
(5.90%)
Today
EarningsMar 24
Vol55,216.00

About ISLMF

InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong.
42

Bearish Sentiment

How do you feel about ISLMF?

Advertisement|Remove ads.